| Central serous chorioretinopathy: towards an evidence-based treatment guideline TJ Van Rijssen, EH Van Dijk, S Yzer, K Ohno-Matsui, JEE Keunen, ... Progress in retinal and eye research 73, 100770, 2019 | 421 | 2019 |
| Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial EHC van Dijk, S Fauser, MB Breukink, R Blanco-Garavito, ... Ophthalmology 125 (10), 1547-1555, 2018 | 315 | 2018 |
| Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders RF Spaide, CMG Cheung, H Matsumoto, S Kishi, CJF Boon, EHC van Dijk, ... Progress in retinal and eye research 86, 100973, 2022 | 239 | 2022 |
| Reshaping ophthalmology training after COVID-19 pandemic M Ferrara, V Romano, DH Steel, R Gupta, C Iovino, EHC van Dijk, ... Eye 34 (11), 2089-2097, 2020 | 158 | 2020 |
| Artificial intelligence‐based chatbot patient information on common retinal diseases using ChatGPT. I Potapenko, LC Boberg‐Ans, M Stormly Hansen, ON Klefter, ... Acta Ophthalmologica (1755375X) 101 (7), 2023 | 127 | 2023 |
| Human iPSC-derived retinas recapitulate the fetal CRB1 CRB2 complex formation and demonstrate that photoreceptors and Müller glia are targets of AAV5 PM Quinn, TM Buck, AA Mulder, C Ohonin, CH Alves, RM Vos, M Bialecka, ... Stem Cell Reports 12 (5), 906-919, 2019 | 102 | 2019 |
| Multimodal imaging-based central serous chorioretinopathy classification J Chhablani, FB Cohen, P Aymard, T Beydoun, E Bousquet, ... Ophthalmology Retina 4 (11), 1043-1046, 2020 | 100 | 2020 |
| Serous retinopathy associated with mitogen-activated protein kinase kinase inhibition (binimetinib) for metastatic cutaneous and uveal melanoma EHC Van Dijk, CML Van Herpen, M Marinkovic, JBAG Haanen, ... Ophthalmology 122 (9), 1907-1916, 2015 | 84 | 2015 |
| Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care MJ Sirks, EHC van Dijk, N Rosenberg, CEM Hollak, S Aslanis, ... Acta ophthalmologica 100 (7), e1522-e1532, 2022 | 76 | 2022 |
| Association of a haplotype in the NR3C2 gene, encoding the mineralocorticoid receptor, with chronic central serous chorioretinopathy EHC van Dijk, RL Schellevis, MGJM van Bergen, MB Breukink, L Altay, ... JAMA ophthalmology 135 (5), 446-451, 2017 | 73 | 2017 |
| Half-dose photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy (SPECTRA): a randomized controlled trial TJ van Rijssen, EHC van Dijk, R Tsonaka, HMA Feenstra, G Dijkman, ... American journal of ophthalmology 233, 101-110, 2022 | 71 | 2022 |
| Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser: PLACE Trial Report No. 3 TJ Van Rijssen, EHC Van Dijk, P Scholz, MB Breukink, R Blanco-Garavito, ... American journal of ophthalmology 205, 1-10, 2019 | 68 | 2019 |
| Role of the complement system in chronic central serous chorioretinopathy: a genome-wide association study RL Schellevis, EHC van Dijk, MB Breukink, L Altay, B Bakker, ... JAMA ophthalmology 136 (10), 1128-1136, 2018 | 66 | 2018 |
| Discrepancy in current central serous chorioretinopathy classification SR Singh, A Matet, EHC Van Dijk, A Daruich, S Fauser, S Yzer, E Peiretti, ... British Journal of Ophthalmology 103 (6), 737-742, 2019 | 62 | 2019 |
| Serous business: delineating the broad spectrum of diseases with subretinal fluid in the macula EHC van Dijk, CJF Boon Progress in Retinal and Eye Research 84, 100955, 2021 | 59 | 2021 |
| Photodynamic therapy for chorioretinal diseases: a practical approach EHC van Dijk, TJ van Rijssen, Y Subhi, CJF Boon Ophthalmology and therapy 9, 329-342, 2020 | 58 | 2020 |
| Exploring the choroidal vascular labyrinth and its molecular and structural roles in health and disease J Brinks, EHC Van Dijk, I Klaassen, RO Schlingemann, SM Kielbasa, ... Progress in retinal and eye research 87, 100994, 2022 | 56 | 2022 |
| Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy D Mohabati, TJ van Rijssen, EHC van Dijk, GPM Luyten, TO Missotten, ... Clinical ophthalmology, 1061-1070, 2018 | 56 | 2018 |
| Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial … MB Breukink, SM Downes, G Querques, EHC van Dijk, AI den Hollander, ... Trials 16, 1-17, 2015 | 54 | 2015 |
| Choroidal anatomic alterations after photodynamic therapy for chronic central serous chorioretinopathy: a multicenter study C Iovino, A Au, J Chhablani, DC Parameswarappa, MA Rasheed, ... American journal of ophthalmology 217, 104-113, 2020 | 51 | 2020 |
